Lv2
160 积分 2026-03-18 加入
Biological and Clinical Implications of Sex Differences in Right Heart Failure Associated With Pulmonary Arterial Hypertension
4个月前
已完结
Real-world safety profile of mitomycin: signal detection and time-to-onset analysis from FDA adverse event reporting system and VigiAccess databases
5个月前
已完结
Postmarketing safety analysis of remimazolam
5个月前
已完结
Chimeric antigen receptor T‐cells safety: A pharmacovigilance and meta‐analysis study
5个月前
已完结
The safety of systemic Janus kinase inhibitors in atopic dermatitis: A systematic review and meta‐analysis of randomized controlled trials
5个月前
已完结
Unsolved Issues on Beneficial Effects of Combination Therapy With Sotatercept in Pulmonary Arterial Hypertension
5个月前
已完结
Sotatercept: The First FDA-Approved Activin A Receptor IIA Inhibitor Used in the Management of Pulmonary Arterial Hypertension
5个月前
已完结
Sotatercept: A New Frontier in Pulmonary Arterial Hypertension Treatment
5个月前
已完结
Sotatercept in pulmonary hypertension and beyond
5个月前
已完结
皖公网安备34019202002308
